title: Abnormal metabolic control in the septic multiple organ failure syndrome: pharmacotherapy for altered fuel control mechanisms.
authors.affiliation: MIEMSS: University of Maryland, Department of Surgery, Baltimore 21201.
authors.forename: J H
authors.initials: JH
authors.lastname: Siegel
authors.forename: T C
authors.initials: TC
authors.lastname: Vary
authors.forename: A
authors.initials: A
authors.lastname: Rivkind
authors.forename: R
authors.initials: R
authors.lastname: Bilik
authors.forename: B
authors.initials: B
authors.lastname: Coleman
authors.forename: B E
authors.initials: BE
authors.lastname: Tall
authors.forename: J G
authors.initials: JG
authors.lastname: Morris
mesh_terms: D000818:Animals; D002245:Carbon Dioxide / Q000378:metabolism; D004734:Energy Metabolism; D005947:Glucose / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D008055:Lipids / Q000627:therapeutic use; D009102:Multiple Organ Failure / Q000503:physiopathology*; D010289:Parenteral Nutrition, Total; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism; D012128:Respiratory Distress Syndrome / Q000378:metabolism; D018805:Sepsis / Q000150:complications / Q000378:metabolism*
chemical_list: D008055:Lipids; D011768:Pyruvate Dehydrogenase Complex; D002245:Carbon Dioxide; D005947:Glucose